Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Investing.com - DA Davidson has reiterated its Neutral rating on salesforce.com (NYSE:CRM) with a price target of $225.00. The software giant, currently trading at $236.58, boasts impressive financials with $39.5B in revenue and an industry-leading 77.65% gross profit margin. According to InvestingPro analysis, the stock appears undervalued based on its Fair Value metrics.
The research firm maintained its position after attending Dreamforce and the accompanying investor day in San Francisco, where Salesforce management provided updates on innovation acceleration and introduced new long-term financial targets. The company’s strong financial health is evidenced by its perfect Piotroski Score of 9, one of several key insights available on InvestingPro.
DA Davidson noted it became "incrementally more positive" about Salesforce’s ability to monetize artificial intelligence following the presentations and updates from company leadership.
Despite the improved outlook on AI monetization, the firm stated it is "not ready to underwrite reacceleration to a 10%+ organic growth CAGR through FY30," explaining its decision to maintain the Neutral stance.
The $225 price target represents a multiple of 18 times the company’s projected FY27 earnings per share, with DA Davidson viewing Agentforce as "a nascent growth component in the near term."
In other recent news, Salesforce has been the focus of several analyst evaluations following key company events. Goldman Sachs reiterated a Buy rating on Salesforce stock with a price target of $385, after the company outlined its long-term guidance aiming for over $60 billion in revenue by fiscal 2030, with operating margins expected to reach 40%. Oppenheimer also reaffirmed an Outperform rating, expressing confidence in Salesforce’s medium-term guidance of a 10% compound annual growth rate (CAGR) and margin expansion over the next 12-18 months. Cantor Fitzgerald maintained an Overweight rating with a $325 price target, highlighting Salesforce’s strategic role in enterprise AI through its Agentforce 360 platform. KeyBanc continued its Overweight rating, setting a price target of $400, and noted comments from Salesforce executives about anticipated growth acceleration. Guggenheim, however, kept a Neutral rating, expressing skepticism about the feasibility of Salesforce’s fiscal 2030 revenue target, which implies a 10%+ organic revenue growth CAGR from FY26 to FY30. These developments reflect a range of perspectives on Salesforce’s future growth and strategic positioning in the market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.